{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:49:17Z","timestamp":1777697357782,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T00:00:00Z","timestamp":1401926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s10822-014-9757-8","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T18:58:29Z","timestamp":1401908309000},"page":"699-710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Ligand efficiency metrics considered harmful"],"prefix":"10.1007","volume":"28","author":[{"given":"Peter W.","family":"Kenny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Leit\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,5]]},"reference":[{"key":"9757_CR1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrd4163","volume":"13","author":"AL Hopkins","year":"2014","unstructured":"Hopkins AL, Keser\u00fc GM, Leeson PD, Rees DC, Reynolds CH (2014) The role of ligand efficiency metrics in drug discovery. Nat Rev Drug Discov 13:105\u2013121","journal-title":"Nat Rev Drug Discov"},{"key":"9757_CR2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10822-013-9655-5","volume":"27","author":"PW Kenny","year":"2013","unstructured":"Kenny PW, Montanari CA, Prokopczyk IM (2013) ClogPalk: a method for predicting alkane\/water partition coefficient. J Comput Aided Mol Des 27:389\u2013402","journal-title":"J Comput Aided Mol Des"},{"key":"9757_CR3","doi-asserted-by":"crossref","unstructured":"Schultz MD (2013) Setting expectations in molecular optimizations: strengths and limitations of commonly used composite parameters. Bioorg Med Chem Lett 23:5980\u20135991","DOI":"10.1016\/j.bmcl.2013.08.029"},{"key":"9757_CR4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/ml4004638","volume":"5","author":"MD Schultz","year":"2014","unstructured":"Schultz MD (2014) Improving the plausibility of success with inefficient metrics. ACS Med Chem Lett 5:2\u20135","journal-title":"ACS Med Chem Lett"},{"key":"9757_CR5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10822-013-9676-0","volume":"27","author":"PW Kenny","year":"2013","unstructured":"Kenny PW, Montanari CA, Prokopczyk IM, Sala FA, Sartori GR (2013) Automated molecule editing in molecular design. J Comput Aided Mol Des 27:655\u2013664","journal-title":"J Comput Aided Mol Des"},{"key":"9757_CR6","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1021\/ci9000234","volume":"49","author":"PW Kenny","year":"2009","unstructured":"Kenny PW (2009) Hydrogen bonding, electrostatic potential and molecular design. J Chem Inf Model 49:1234\u20131244","journal-title":"J Chem Inf Model"},{"key":"9757_CR7","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1021\/jm991118x","volume":"43","author":"A Linusson","year":"2000","unstructured":"Linusson A, Gottfries J, Lindgren F, Wold S (2000) Statistical molecular design of building blocks for combinatorial chemistry. J Med Chem 43:1320\u20131328","journal-title":"J Med Chem"},{"key":"9757_CR8","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1021\/jm000407e","volume":"44","author":"H Waterbeemd van de","year":"2001","unstructured":"van de Waterbeemd H, Smith DA, Beaumont K, Walker DK (2001) Property-based design: optimization of drug absorption and pharmacokinetics. J Med Chem 44:1313\u20131333","journal-title":"J Med Chem"},{"key":"9757_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3\u201325","journal-title":"Adv Drug Deliv Rev"},{"key":"9757_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10822-012-9631-5","volume":"27","author":"PW Kenny","year":"2013","unstructured":"Kenny PW, Montanari CA (2013) Inflation of correlation in the pursuit of drug-likeness. J Comput Aided Mol Des 27:1\u201313","journal-title":"J Comput Aided Mol Des"},{"key":"9757_CR11","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1039\/c3md00072a","volume":"4","author":"D Muthas","year":"2013","unstructured":"Muthas D, Boyer S, Hasselgren C (2013) A critical assessment of modeling safety-related drug attrition. Med Chem Commun 4:1058\u20131065","journal-title":"Med Chem Commun"},{"key":"9757_CR12","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1021\/jm040031v","volume":"47","author":"DA Erlanson","year":"2004","unstructured":"Erlanson DA, McDowell RS, O\u2019Brien T (2004) Fragment-based drug discovery. J Med Chem 47:3463\u20133482","journal-title":"J Med Chem"},{"key":"9757_CR13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1039\/b610069b","volume":"2","author":"AR Leach","year":"2006","unstructured":"Leach AR, Hann MM, Burrows JN, Griffen EJ (2006) Fragment screening: an introduction. Mol BioSyst 2:429\u2013446","journal-title":"Mol BioSyst"},{"key":"9757_CR14","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1021\/jm060511h","volume":"49","author":"PJ Hajduk","year":"2006","unstructured":"Hajduk PJ (2006) Fragment-based drug design: how big is too big? J Med Chem 49:6972\u20136976","journal-title":"J Med Chem"},{"key":"9757_CR15","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.2174\/156802607782341091","volume":"7","author":"JS Albert","year":"2007","unstructured":"Albert JS, Blomberg N, Breeze AL, Brown AJH, Burrows JN, Edwards PD, Folmer RHA, Geschwindner S, Griffen EJ, Kenny PW, Nowak T, Olsson L, Sanganee H, Shapiro AB (2007) An integrated approach to fragment-based lead generation: philosophy, strategy and case studies from AstraZeneca\u2019s drug discovery programs. Curr Top Med Chem 7:1600\u20131629","journal-title":"Curr Top Med Chem"},{"key":"9757_CR16","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1021\/jm8000373","volume":"51","author":"M Congreve","year":"2008","unstructured":"Congreve M, Chessari G, Tisi D, Woodhead AJ (2008) Recent developments in fragment-based drug discovery. J Med Chem 51:3661\u20133680","journal-title":"J Med Chem"},{"key":"9757_CR17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10822-009-9264-5","volume":"23","author":"N Blomberg","year":"2009","unstructured":"Blomberg N, Cosgrove DA, Kenny PW, Kolmodin K (2009) Design of compound libraries for fragment screening. J Comput Aided Mol Des 23:513\u2013525","journal-title":"J Comput Aided Mol Des"},{"key":"9757_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/128_2011_180","volume":"317","author":"DA Erlanson","year":"2012","unstructured":"Erlanson DA (2012) Introduction to fragment-based drug discovery. Top Curr Chem 317:1\u201332","journal-title":"Top Curr Chem"},{"key":"9757_CR19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1021\/ci400731w","volume":"54","author":"D Joseph-McCarthy","year":"2014","unstructured":"Joseph-McCarthy D, Campbell AJ, Kern G, Moustakas D (2014) Fragment-based lead discovery and design. J Chem Inf Model 54:693\u2013704","journal-title":"J Chem Inf Model"},{"key":"9757_CR20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.drudis.2010.08.004","volume":"15","author":"C Abad-Zapatero","year":"2010","unstructured":"Abad-Zapatero C, Peri\u0161i\u0107 O, Wass J, Bento AP, Overington J, Al-Lazikani B, Johnson ME (2010) Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation. Drug Discov Today 15:805\u2013811","journal-title":"Drug Discov Today"},{"key":"9757_CR21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4155\/fmc.14.16","volume":"6","author":"C Abad-Zapatero","year":"2014","unstructured":"Abad-Zapatero C, Champness EJ, Segall MD (2014) Alternative variables in drug discovery: promises and challenges. Future Med Chem 6:577\u2013593","journal-title":"Future Med Chem"},{"key":"9757_CR22","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nrd3287","volume":"9","author":"DA Smith","year":"2010","unstructured":"Smith DA, Di L, Kerns EH (2010) The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nat Rev Drug Discov 9:929\u2013939","journal-title":"Nat Rev Drug Discov"},{"key":"9757_CR23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1359-6446(04)03069-7","volume":"9","author":"AL Hopkins","year":"2004","unstructured":"Hopkins AL, Groom CR, Alex A (2004) Ligand efficiency: a useful metric for lead selection. Drug Discov Today 9:430\u2013431","journal-title":"Drug Discov Today"},{"key":"9757_CR24","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/minf.201000061","volume":"29","author":"A Tropsha","year":"2011","unstructured":"Tropsha A (2011) Best practices for QSAR model development, validation and exploitation. Mol Inform 29:476\u2013488","journal-title":"Mol Inform"},{"key":"9757_CR25","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0006-3495(97)78756-3","volume":"72","author":"MK Gilson","year":"1997","unstructured":"Gilson MK, Given JA, Bush BL, McCammon JA (1997) The statistical-thermodynamic basis for computation of binding affinities: a critical review. Biophys J 72:1047\u20131069","journal-title":"Biophys J"},{"key":"9757_CR26","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1021\/cr800551w","volume":"109","author":"H-X Zhou","year":"2009","unstructured":"Zhou H-X, Gilson MK (2009) Theory of free energy and entropy in noncovalent binding. Chem Rev 109:4092\u20134107","journal-title":"Chem Rev"},{"key":"9757_CR27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.biophys.36.040306.132550","volume":"36","author":"MK Gilson","year":"2011","unstructured":"Gilson MK, Zhou H-X (2011) Calculation of protein-ligand binding affinities. Annu Rev Biophys Biomol Struct 36:21\u201342","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"9757_CR28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10822-011-9435-z","volume":"25","author":"PN Mortenson","year":"2011","unstructured":"Mortenson PN, Murray CW (2011) Assessing the lipophilicity of fragments and early hits. J Comput Aided Mol Des 25:663\u2013667","journal-title":"J Comput Aided Mol Des"},{"key":"9757_CR29","doi-asserted-by":"crossref","first-page":"9997","DOI":"10.1073\/pnas.96.18.9997","volume":"96","author":"ID Kuntz","year":"1999","unstructured":"Kuntz ID, Chen K, Sharp KA, Kollman PA (1999) The maximal affinity of ligands. Proc Natl Acad Sci 96:9997\u201310002","journal-title":"Proc Natl Acad Sci"},{"key":"9757_CR30","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1021\/ci200612f","volume":"52","author":"RD Smith","year":"2012","unstructured":"Smith RD, Engdahl AL, Dunbar JB, Carlson HA (2012) Biophysical limits of protein-ligand binding. J Chem Inf Model 52:2098\u20132106","journal-title":"J Chem Inf Model"},{"key":"9757_CR31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1039\/cs9932200073","volume":"22","author":"MH Abraham","year":"1993","unstructured":"Abraham MH (1993) Scales of solute hydrogen-bonding: their construction and application to physicochemical and biochemical processes. Chem Soc Rev 22:73\u201383","journal-title":"Chem Soc Rev"},{"key":"9757_CR32","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1021\/jm100112j","volume":"53","author":"C Bissantz","year":"2010","unstructured":"Bissantz C, Kuhn B, Stahl M (2010) A medicinal chemist\u2019s guide to molecular interactions. J Med Chem 53:5061\u20135084","journal-title":"J Med Chem"},{"key":"9757_CR33","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/ci000403i","volume":"41","author":"MM Hann","year":"2001","unstructured":"Hann MM, Leach AR, Harper G (2001) Molecular complexity and its impact on the probability of finding leads for drug discovery. J Chem Inf Comp Sci 41:856\u2013864","journal-title":"J Chem Inf Comp Sci"},{"key":"9757_CR34","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1021\/jm701255b","volume":"51","author":"CH Reynolds","year":"2008","unstructured":"Reynolds CH, Tounge BA, Bembenek SD (2008) Ligand binding efficiency: trends, physical basis, and implications. J Med Chem 51:2432\u20132438","journal-title":"J Med Chem"},{"key":"9757_CR35","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0076-6879(79)63019-7","volume":"63","author":"JW Williams","year":"1979","unstructured":"Williams JW, Morrison JF (1979) The kinetics of reversible tight-binding inhibition. Methods Enymol 63:437\u2013467","journal-title":"Methods Enymol"},{"key":"9757_CR36","first-page":"465","volume":"10","author":"C Abad-Zapatero","year":"2005","unstructured":"Abad-Zapatero C, Metz JT (2005) Ligand efficiency indices as guideposts for drug discovery. Drug Discov Today 10:465\u2013469","journal-title":"Drug Discov Today"},{"key":"9757_CR37","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.bmcl.2009.07.083","volume":"19","author":"G Lloyd","year":"2009","unstructured":"Lloyd G, Czaplewskia LG, Collins I, Boyd EA, Brown D, East SP, Gardiner M, Fletcher R, Haydon DJ, Henstock V, Ingram P, Jones C, Noula C, Kennison L, Rockley C, Rose V, Thomaides-Brears HB, Ure R, Whittaker M, Stokes NR (2009) Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ. Bioorg Med Chem Lett 19:524\u2013527","journal-title":"Bioorg Med Chem Lett"},{"key":"9757_CR38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrd3054","volume":"9","author":"JE Ladbury","year":"2010","unstructured":"Ladbury JE, Klebe G, Freire E (2010) Adding calorimetric data to decision making in lead discovery: a hot tip. Nat Rev Drug Discov 9:23\u201327","journal-title":"Nat Rev Drug Discov"},{"key":"9757_CR39","doi-asserted-by":"crossref","unstructured":"Lewis ML, Cucurull-Sanchez L (2009) Structural pairwise comparisons of HLM stability of phenyl derivatives: introduction of the Pfizer metabolism index (PMI) and metabolism-lipophilicity efficiency (MLE). J Comput Aided Mol Des 23:97\u2013103","DOI":"10.1007\/s10822-008-9242-3"},{"key":"9757_CR40","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.drudis.2011.09.006","volume":"16","author":"GA Holdgate","year":"2011","unstructured":"Holdgate GA, Gill AL (2011) Kinetic efficiency: the missing metric for enhancing compound quality? Drug Discov Today 16:910\u2013913","journal-title":"Drug Discov Today"},{"key":"9757_CR41","doi-asserted-by":"crossref","unstructured":"Murray CW, Erlanson DA, Hopkins AL, Keser\u00fc GM, Leeson PD, Rees DC, Reynolds CH, Richmond NJ (2014) Validity of ligand efficiency metrics. ACS Med Chem Lett ASAP. 10.1021\/ml500146d","DOI":"10.1021\/ml500146d"},{"key":"9757_CR42","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/cmdc.200800132","volume":"3","author":"ML Verdonk","year":"2008","unstructured":"Verdonk ML, Rees DC (2008) Group efficiency: a guideline for hits-to-leads chemistry. ChemMedChem 3:1179\u20131180","journal-title":"ChemMedChem"},{"key":"9757_CR43","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","volume":"6","author":"PD Leeson","year":"2007","unstructured":"Leeson PD, Springthorpe B (2007) The influence of drug-like concepts on decision-making in medicinal chemistry. Nat Rev Drug Discov 6:881\u2013890","journal-title":"Nat Rev Drug Discov"},{"key":"9757_CR44","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1016\/j.bmcl.2009.05.062","volume":"19","author":"T Ryckmans","year":"2009","unstructured":"Ryckmans T, Edwards MP, Horne VA, Correia AM, Owen DR, Thompson LR, Tran I, Tutt MF, Young T (2009) Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: a lipophilic efficiency (LipE) analysis. Bioorg Med Chem Lett 19:4406\u20134409","journal-title":"Bioorg Med Chem Lett"},{"key":"9757_CR45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd2796","volume":"8","author":"GM Keser\u00fc","year":"2009","unstructured":"Keser\u00fc GM, Makara GM (2009) The influence of lead discovery strategies on the properties of drug candidates. Nat Rev Drug Discov 8:203\u2013212","journal-title":"Nat Rev Drug Discov"},{"key":"9757_CR46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4155\/fmc.12.208","volume":"5","author":"KD Freeman-Cook","year":"2013","unstructured":"Freeman-Cook KD, Hoffman RL, Johnson TW (2013) Lipophilic efficiency: the most important efficiency metric in medicinal chemistry. Future Med Chem 5:113\u2013115","journal-title":"Future Med Chem"},{"key":"9757_CR47","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/jps.21494","volume":"98","author":"R Mannhold","year":"2009","unstructured":"Mannhold R, Poda GI, Ostermann C, Tetko IV (2009) Calculation of molecular lipophilicity: state-of-the-art and comparison of log P methods on more than 96,000 compounds. J Pharm Sci 98:861\u2013893","journal-title":"J Pharm Sci"},{"key":"9757_CR48","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1002\/jps.23305","volume":"101","author":"K Valko","year":"2012","unstructured":"Valko K, Chiaparin E, Nunhuck S, Montanari D (2012) In vitro measurement of drug efficiency index to aid early lead optimization. J Pharm Sci 101:4155\u20134169","journal-title":"J Pharm Sci"},{"key":"9757_CR49","doi-asserted-by":"crossref","unstructured":"McTigue M, Murray BW, Jeffrey H. Chen JH, Denga Y-L, Solowiej J, Kania RS (2012) Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors. Proc Nat Acad Sci109:18281\u201318289","DOI":"10.1073\/pnas.1207759109"},{"key":"9757_CR50","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1016\/j.bmcl.2013.08.030","volume":"23","author":"MD Schultz","year":"2013","unstructured":"Schultz MD (2013) The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations. Bioorg Med Chem Lett 23:5992\u20136000","journal-title":"Bioorg Med Chem Lett"},{"key":"9757_CR51","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/jps.2600830806","volume":"83","author":"MH Abraham","year":"1994","unstructured":"Abraham MH, Chadha HS, Whiting GS, Mitchell RC (1994) Hydrogen bonding. 32. An analysis of water-octanol and water-alkane partitioning and the \u0394logP parameter of Seiler. J Pharm Sci 83:1085\u20131100","journal-title":"J Pharm Sci"},{"key":"9757_CR52","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1039\/C2CS35348B","volume":"42","author":"DT Manallack","year":"2013","unstructured":"Manallack DT, Prankerd RJ, Yuriev E, Oprea TI, Chalmers DK (2013) The significance of acid\/base properties in drug discovery. Chem Soc Rev 42:485\u2013496","journal-title":"Chem Soc Rev"},{"key":"9757_CR53","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1021\/ja01264a055","volume":"64","author":"PH Bell","year":"1942","unstructured":"Bell PH, Roblin RO (1942) Studies in chemotherapy. VII. A theory of the relation of structure to activity of sulfanilamide type compounds. J Am Chem Soc 64:2905\u20132917","journal-title":"J Am Chem Soc"},{"key":"9757_CR54","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1039\/P29860001765","volume":"2","author":"PJ Taylor","year":"1986","unstructured":"Taylor PJ, Wait AR (1986) \u03c3i Values for heterocycles. J Chem Soc Perkin Trans 2:1765\u20131770","journal-title":"J Chem Soc Perkin Trans"},{"key":"9757_CR55","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1021\/jm201388p","volume":"55","author":"A Tarcsay","year":"2012","unstructured":"Tarcsay A, Nyiri K, Keser\u0171 GM (2012) Impact of lipophilic efficiency on compound quality. J Med Chem 55:1252\u20131260","journal-title":"J Med Chem"},{"key":"9757_CR56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1099-128X(199903\/04)13:2<111::AID-CEM532>3.0.CO;2-N","volume":"13","author":"J Kalivas","year":"1999","unstructured":"Kalivas J (1999) Interrelationships of multivariate regression methods using eigenvector basis sets. J Chemom 13:111\u2013132","journal-title":"J Chemom"},{"key":"9757_CR57","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1021\/ci060117s","volume":"46","author":"GM Maggiora","year":"2006","unstructured":"Maggiora GM (2006) On outliers and activity cliffs\u2014why QSAR often disappoints. J Chem Inf Model 46:1535","journal-title":"J Chem Inf Model"},{"key":"9757_CR58","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1021\/ci7004093","volume":"48","author":"R Guha","year":"2008","unstructured":"Guha R, Van Drie JH (2008) Structure-activity landscape index: identifying and quantifying activity cliffs. J Chem Inf Model 48:646\u2013658","journal-title":"J Chem Inf Model"},{"key":"9757_CR59","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1021\/jm201706b","volume":"55","author":"D Stumpfe","year":"2012","unstructured":"Stumpfe D, Bajorath J (2012) Exploring activity cliffs in medicinal chemistry. J Med Chem 55:2932\u20132942","journal-title":"J Med Chem"},{"key":"9757_CR60","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0959-440X(02)00283-X","volume":"12","author":"WL DeLano","year":"2002","unstructured":"DeLano WL (2002) Unraveling hot spots in binding interfaces: progress and challenges. Curr Opin Struct Biol 12:14\u201320","journal-title":"Curr Opin Struct Biol"},{"key":"9757_CR61","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.bmcl.2005.03.068","volume":"15","author":"E Black","year":"2005","unstructured":"Black E, Breed J, Breeze AL, Embrey K, Garcia R, Gero TW, Godfrey L, Kenny PW, Morley AD, Minshull CA, Pannifer AD, Read J, Rees A, Russell DJ, Toader D, Tucker J (2005) Structure-based design of protein tyrosine phosphatase-1B inhibitors. Bioorg Med Chem Lett 15:2503\u20132507","journal-title":"Bioorg Med Chem Lett"},{"key":"9757_CR62","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/minf.201000074","volume":"29","author":"E Lind","year":"2010","unstructured":"Lind E (2010) QSAR analysis involving assay results which are only known to be greater than, or less than some cut-off limit. Mol Inform 29:845\u2013852","journal-title":"Mol Inform"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-014-9757-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-014-9757-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-014-9757-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T21:23:04Z","timestamp":1559251384000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-014-9757-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,5]]},"references-count":62,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["9757"],"URL":"https:\/\/doi.org\/10.1007\/s10822-014-9757-8","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718446556.793497927","asserted-by":"object"}]},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,5]]}}}